Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Report on how AI is redefining market landscape - The global gastroparesis drugs market  size is estimated to grow by USD 1.42 billion from 2024-2028, according to Technavio. The market is estimated ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

The FreeStyle Libre 3 Plus worn during an imaging procedure. [Image courtesy of Abbott] Abbott (NYSE:ABT) announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during ...

so sites must reevaluate their quality and safety credentials and maintain a state of good manufacturing practice (GMP) readiness. Throughout the pandemic, the lack of FDA inspections has created ...

Oct. 29, 2024 (GLOBE NEWSWIRE) -- 2ONE Labs Inc., is pleased to announce the 'Acceptance' of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration ...

Acknowledging receipt of the FDA ‘Acceptance’ notification, Vincent Schuman, CEO of 2ONE Labs, said: “This means the 2ONE® PMTA application will now move forward to the next important stage of FDA ...

The Biden administration took steps to alleviate shortages of cancer drugs for children, part of a final push for one of the president’s domestic priorities: reducing the nation’s cancer ...

Tidepool today announced a new data integration with Abbott for the company’s FreeStyle Libre continuous glucose monitors (CGMs). The companies aim to deliver cloud-to-cloud integration for an ...

Hindustan Antibiotics and Ipca Laboratories. Drug Controller General Rajeev Singh Raghuvanshi assured that periodic inspections aim to minimize less efficacious drugs. Out of 3,000 samples tested ...